SCHEMBL29841237

SCHEMBL29841237

NCC1COc2ccccc2O1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 2/20 0.60
ADRA1A P35348 2/20 0.60
HTR1A P08908 1/20 0.60
DRD1 P21728 1/20 0.60
TBXA2R P21731 1/20 0.60
SLC6A2 P23975 1/20 0.60
DRD3 P35462 1/20 0.60
CA2 P00918 4/20 0.57
HTT P42858 1/20 0.56
ADRA2B P18089 1/20 0.56
ADRA2C P18825 1/20 0.56
ADRA1D P25100 1/20 0.56
ADRA1B P35368 1/20 0.56
SCN1A P35498 1/20 0.56
SCN2A Q99250 1/20 0.56
SCN3A Q9NY46 1/20 0.56
ALOX5 P09917 1/20 0.55
POLB P06746 1/20 0.53
ESR2 Q92731 1/20 0.53
MTNR1A P48039 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8186813 1.00 ADRA2A (0.60) ADRA2AADRA1AHTR1ADRD1TBXA2R
SCHEMBL439092 1.00 ADRA2A (0.60) ADRA2AADRA1AHTR1ADRD1TBXA2R
SCHEMBL407540 1.00 ADRA2A (0.60) ADRA2AADRA1AHTR1ADRD1TBXA2R
SCHEMBL31407451 1.00 ADRA2A (0.60) ADRA2AADRA1AHTR1ADRD1TBXA2R
Hydrochloric Acid SCHEMBL783118 0.98 ADRA2A (0.58) ADRA2AADRA1AHTR1ADRD1TBXA2R
Bromide SCHEMBL11489853 0.98 ADRA2A (0.58) ADRA2AADRA1AHTR1ADRD1TBXA2R
SCHEMBL406531 0.85 HTT (0.61) ADRA2AADRA1AHTR1ADRD1TBXA2R
Hydrochloric Acid SCHEMBL8179101 0.83 HTT (0.59) ADRA2AADRA1AHTR1ADRD1TBXA2R
SCHEMBL568115 0.80 ADRA2A (0.60) ADRA2AADRA1AHTR1ADRD1TBXA2R
SCHEMBL11484814 0.80 ADRA2A (0.56) ADRA2AADRA1AHTR1ADRD1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117355303-A Compounds and their use for the treatment of neurodegenerative, degenerative and metabolic disorders 佛罗里达大学研究基金会公司 2024-01-05 CN disclosed
EP-4284372-A1 COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS University of Florida Research Foundation, Incorporated (US) 2023-12-06 EP disclosed
WO-2022165173-A1 COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2022-08-04 WO disclosed